How does the risk of incident cancer differ with the use of tumor necrosis factor inhibitors (TNFis), non-TNFis, or Janus kinase inhibitors (JAKis) in a US population of patients with rheumatoid arthritis? The gene discussed is TNF; the disease is rheumatoid arthritis.